123 related articles for article (PubMed ID: 3444385)
1. Antineoplastic activity of the thioether lysophospholipid derivative BM 41.440 in vitro.
Fromm M; Berdel WE; Schick HD; Fink U; Pahlke W; Bicker U; Reichert A; Rastetter J
Lipids; 1987 Nov; 22(11):916-8. PubMed ID: 3444385
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
Schick HD; Berdel WE; Fromm M; Fink U; Jehn U; Ulm K; Reichert A; Eibl H; Unger C; Rastetter J
Lipids; 1987 Nov; 22(11):904-10. PubMed ID: 3444383
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of thioether-lysophospholipids in leukemias and tumors of human origin.
Berdel WE; Fromm M; Fink U; Pahlke W; Bicker U; Reichert A; Rastetter J
Cancer Res; 1983 Nov; 43(11):5538-43. PubMed ID: 6577950
[TBL] [Abstract][Full Text] [Related]
4. Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro.
Danhauser S; Berdel WE; Schick HD; Fromm M; Reichert A; Fink U; Busch R; Eibl H; Rastetter J
Lipids; 1987 Nov; 22(11):911-5. PubMed ID: 3444384
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo cytotoxicity of alkyl lysophospholipid ET-18-OCH3 and thioether lipid BM 41.440.
Leder GH; Fiebig HH; Wallbrecher E; Winterhalter BR; Löhr GW
Lipids; 1987 Nov; 22(11):958-61. PubMed ID: 3444393
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic activity of the thioether phospholipid analogue BM 41.440 in primary human tumor cultures.
Herrmann DB; Neumann HA
Lipids; 1987 Nov; 22(11):955-7. PubMed ID: 3444392
[TBL] [Abstract][Full Text] [Related]
7. Ether lipids and analogs in experimental cancer therapy. A brief review of the Munich experience.
Berdel WE
Lipids; 1987 Nov; 22(11):970-3. PubMed ID: 3328030
[TBL] [Abstract][Full Text] [Related]
8. Effect of lipid derivatives on invasion in vitro and on surface glycoproteins of three rodent cell types.
Storme GA; Bruyneel EA; Schallier DC; Bolscher JG; Berdel WE; Mareel MM
Lipids; 1987 Nov; 22(11):847-50. PubMed ID: 3444376
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of the alkyl-linked lipoidal amine 4-aminomethyl-1-[2,3-(di-n-decyloxy)-n-propyl]-4-phenylpiperidine (CP-46,665) in cells from human tumors and leukemias.
Berdel WE; Schick HD; Fink U; Reichert A; Ulm K; Rastetter J
Cancer Res; 1985 Mar; 45(3):1206-13. PubMed ID: 3971369
[TBL] [Abstract][Full Text] [Related]
10. Structure-function relationships of alkyl-lysophospholipid analogs in selective antitumor activity.
Vogler WR; Olson AC; Hajdu J; Shoji M; Raynor R; Kuo JF
Lipids; 1993 Jun; 28(6):511-6. PubMed ID: 8355577
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro.
Berdel WE; Korth R; Reichert A; Houlihan WJ; Bicker U; Nomura H; Vogler WR; Benveniste J; Rastetter J
Anticancer Res; 1987; 7(6):1181-7. PubMed ID: 3442414
[TBL] [Abstract][Full Text] [Related]
12. Comparison of selective cytotoxicity of alkyl lysophospholipids.
Vogler WR; Olson AC; Okamoto S; Shoji M; Raynor RL; Kuo JF; Berdel WE; Eibl H; Hajdu J; Nomura H
Lipids; 1991 Dec; 26(12):1418-23. PubMed ID: 1819744
[TBL] [Abstract][Full Text] [Related]
13. Experimental studies on the role of alkyl lysophospholipids in autologous bone marrow transplantation.
Vogler WR; Olson AC; Okamoto S; Somberg LB; Glasser L
Lipids; 1987 Nov; 22(11):919-24. PubMed ID: 3328027
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitro.
Danhauser-Riedl S; Himmelmann A; Steinhauser G; Busch R; Vogler WR; Rastetter J; Berdel WE
J Lipid Mediat; 1990; 2(5):271-80. PubMed ID: 2133272
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cells.
Berdel WE; Greiner E; Fink U; Stavrou D; Reichert A; Rastetter J; Hoffman DR; Snyder F
Cancer Res; 1983 Feb; 43(2):541-5. PubMed ID: 6848177
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effects of alkyl-lysophospholipids in human brain tumor cells.
Berdel WE; Greiner E; Fink U; Zänker KS; Stavrou D; Trappe A; Fahlbusch R; Reichert A; Rastetter J
Oncology; 1984; 41(2):140-5. PubMed ID: 6709277
[TBL] [Abstract][Full Text] [Related]
17. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
[TBL] [Abstract][Full Text] [Related]
18. BM 41.440: a new antineoplastic, antimetastatic, and immune-stimulating drug.
Herrmann DB; Bicker U; Pahlke W
Cancer Detect Prev Suppl; 1987; 1():361-71. PubMed ID: 3480059
[TBL] [Abstract][Full Text] [Related]
19. Purging murine leukemic marrow with alkyl-lysophospholipids.
Glasser L; Somberg LB; Vogler WR
Blood; 1984 Dec; 64(6):1288-91. PubMed ID: 6388666
[TBL] [Abstract][Full Text] [Related]
20. Clonogenicity of normal and malignant hematopoietic progenitor cells after exposure to synthetic alkyl-lymphospholipids.
Dulisch I; Neumann HA; Löhr GW; Andreesen R
Blut; 1985 Dec; 51(6):393-9. PubMed ID: 3865693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
